Board Moves December 1, 2017
Friday, 1 December, 2017 - 16:28
Peter Clare has been appointed non-executive chair of Dubber Corporation. Current chair Peter Pawlowitsch will become non-executive director.
Dr George Morstyn is a pioneering drug developer, with many new products receiving marketing approval and having been launched during his tenure with US biotech giant Amgen.
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
625th | Aquirian">Aquirian | 14.29% | 0% |
626th | Globe International">Globe International | 14.18% | 27.3% |
627th | Actinogen Medical">Actinogen Medical | 14.13% | -8.42% |
628th | Central Petroleum">Central Petroleum | 13.97% | -20.17% |
629th | Alterity Therapeutics">Alterity Therapeutics | 13.95% | -30.54% |
REMUNERATION UPDATE: Non-Executive Director, Actinogen Medical | 03 Nov 2020 |
Peter Clare has been appointed non-executive chair of Dubber Corporation. Current chair Peter Pawlowitsch will become non-executive director.
Access to our data for George Morstyn is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
George Morstyn is linked to 1 organisation which is included in 1 list - Public Companies - non WA.
To see the data you will need to Subscribe.